For Immediate Release – July 25, 2023 Tarsus Pharmaceuticals, Inc, Irvine, CA, announced the U.S. Food and Drug Administration (FDA) has approved XDEMVY (lotilaner ophthalmic solution) 0.25% indicated for the…
For Immediate Release Allergan, an AbbVie company announced the U.S. Food and Drug Administration (FDA) has approved VUITY™ (pilocarpine HCl ophthalmic solution) 1.25% for the treatment of presbyopia, commonly known as age-related…
October 19, 2021 For Immediate Release Oyster Point Pharma, a Princeton NJ company, has announced the FDA has approved Tyrvaya™ as the first and only nasal spray approved for treating…
October 18, 2021 For Immediate Release Ocular Therapeutix, a Bedford MA company, has announced the FDA has approved Dextenza® for treating ocular itching associated with allergic conjunctivitis. John C. Meyer,…